Bhagiradha Chemicals & Industries Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹169.9 Cr (+21% YoY), EBITDA ₹22.7 Cr (13.4% margin), PAT ₹5.4 Cr (-2% YoY). H1 PAT ₹18.7 Cr (+98%). Volumes soft; margins compressed QoQ.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Q2 FY27 revenue ₹169.9 Cr (+21% YoY), EBITDA ₹22.7 Cr (13.4% margin), PAT ₹5.4 Cr (-2% YoY). H1 PAT ₹18.7 Cr (+98%). Volumes soft; margins compressed QoQ.
Q1FY27 recorded highest-ever quarterly performance with ₹195 Cr revenue. Strategy shifts toward high-margin molecules and scaling the new Bheema facility.
Bhagiradha Chemicals delivered solid FY26 performance with 22% revenue growth and 55% EBITDA expansion, driven by improved volumes and capacity utilization following Bheema facility commissioning.